Download this Infographic today!
Discover how high-throughput screening cytometry is transforming CAR-T development from months-long processes into weeks of parallel profiling. This infographic reveals practical strategies to accelerate antibody discovery, systematically screen dozens of CAR construct configurations, and generate the multiparametric data needed to advance safer, more effective immunotherapies to the clinic faster.
Inside this infographic, you’ll learn:
- How HTS cytometry screens 100+ CAR constructs per day versus limited constructs per week with traditional methods
- Real-world case studies: BAFF-R domain discovery and HER2 CAR-T safety profiling using 3D spheroid screens
Click ‘LOOK INSIDE’ to download the PDF now.
LOOK INSIDE
More Information
The race to develop more effective CAR-T therapies demands faster, smarter screening methods. High-throughput screening (HTS) cytometry platforms are answering that call. Modern integrated workflows combining flow cytometry with live-cell analysis enable researchers to implement comprehensive quality control throughout the entire CAR-T development pipeline—from initial antibody screening to final product release.
Brought to you by
Sponsored by
Sartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing.